Literature DB >> 3110835

Nicotine and smoking: a perspective from animal studies.

P B Clarke.   

Abstract

Nicotine plays a key role in reinforcing tobacco smoking, and exerts several psychoneuropharmacological actions which may contribute to its reinforcing effects. Thus, nicotine can improve mood and alleviate withdrawal symptoms; it can also alter CNS arousal, reduce stress, suppress appetite, and improve performance on certain tasks. Behavioural studies in animals have tended to corroborate existing theories of smoking behaviour, and have started to suggest how and where nicotine may exert its central actions in man. Clinical evidence suggests that smoking cessation would be facilitated by the administration of a nicotinic antagonist having a selective action on central nicotinic cholinoceptors of the C6 (ganglionic) type. Pharmacological studies in animals indicate that such a drug is a reasonable prospect.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3110835     DOI: 10.1007/bf00177905

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  47 in total

1.  New evidence for a relationship between tobacco smoking, nicotine dependence and stress.

Authors:  G H Hall; C F Morrison
Journal:  Nature       Date:  1973-05-25       Impact factor: 49.962

2.  Persistent behavior at high rates maintained by intravenous self-administration of nicotine.

Authors:  S R Goldberg; R D Spealman; D M Goldberg
Journal:  Science       Date:  1981-10-30       Impact factor: 47.728

3.  Cholinergic receptor interactions and their effects on long-term memory processing.

Authors:  J F Flood; D W Landry; M E Jarvik
Journal:  Brain Res       Date:  1981-06-29       Impact factor: 3.252

4.  Effect of nicotine on the tobacco withdrawal syndrome.

Authors:  J R Hughes; D K Hatsukami; R W Pickens; D Krahn; S Malin; A Luknic
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

5.  Mecamylamine blockade of nicotine responses: evidence for two brain nicotinic receptors.

Authors:  A C Collins; C B Evans; L L Miner; M J Marks
Journal:  Pharmacol Biochem Behav       Date:  1986-06       Impact factor: 3.533

6.  Nicotine self-administration in rats.

Authors:  B M Cox; A Goldstein; W T Nelson
Journal:  Br J Pharmacol       Date:  1984-09       Impact factor: 8.739

7.  Characteristics of conditioned taste aversion produced by nicotine in rats.

Authors:  R Kumar; J A Pratt; I P Stolerman
Journal:  Br J Pharmacol       Date:  1983-05       Impact factor: 8.739

8.  The effects of nicotine on locomotor activity in non-tolerant and tolerant rats.

Authors:  P B Clarke; R Kumar
Journal:  Br J Pharmacol       Date:  1983-02       Impact factor: 8.739

9.  Tolerance, cross-tolerance, and receptors after chronic nicotine or oxotremorine.

Authors:  M J Marks; A C Collins
Journal:  Pharmacol Biochem Behav       Date:  1985-02       Impact factor: 3.533

10.  Exposure to nicotine enhances the behavioral stimulant effect of nicotine and increases binding of [3H]acetylcholine to nicotinic receptors.

Authors:  C Ksir; R Hakan; D P Hall; K J Kellar
Journal:  Neuropharmacology       Date:  1985-06       Impact factor: 5.250

View more
  35 in total

Review 1.  Nicotinic acetylcholine receptors: upregulation, age-related effects and associations with drug use.

Authors:  W E Melroy-Greif; J A Stitzel; M A Ehringer
Journal:  Genes Brain Behav       Date:  2015-12-23       Impact factor: 3.449

2.  Effects of systemic and intracerebroventricular administration of mecamylamine, a nicotinic cholinergic antagonist, on spatial memory in rats.

Authors:  M W Decker; M J Majchrzak
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

3.  Discovery of a novel nicotinic receptor antagonist for the treatment of nicotine addiction: 1-(3-Picolinium)-12-triethylammonium-dodecane dibromide (TMPD).

Authors:  Linda P Dwoskin; B Matthew Joyce; Guangrong Zheng; Nichole M Neugebauer; Vamshi K Manda; Paul Lockman; Roger L Papke; Michael T Bardo; Peter A Crooks
Journal:  Biochem Pharmacol       Date:  2007-07-21       Impact factor: 5.858

4.  Sensitivity and tolerance to nicotine in smokers and nonsmokers.

Authors:  E D Srivastava; M A Russell; C Feyerabend; J G Masterson; J Rhodes
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

5.  Reinforcement enhancement by nicotine in adult rats: behavioral selectivity and relation to mode of delivery and blood nicotine levels.

Authors:  Annie Constantin; Paul B S Clarke
Journal:  Psychopharmacology (Berl)       Date:  2017-11-11       Impact factor: 4.530

6.  Introduction of unsaturation into the N-n-alkyl chain of the nicotinic receptor antagonists, NONI and NDNI: effect on affinity and selectivity.

Authors:  Sangeetha P Sumithran; Peter A Crooks; Rui Xu; Jun Zhu; Agripina G Deaciuc; Lincoln H Wilkins; Linda P Dwoskin
Journal:  AAPS J       Date:  2005-08-29       Impact factor: 4.009

7.  Locomotor activation and dopamine release produced by nicotine and isoarecolone in rats.

Authors:  P Whiteaker; H S Garcha; S Wonnacott; I P Stolerman
Journal:  Br J Pharmacol       Date:  1995-10       Impact factor: 8.739

8.  Nicotinic systems and cognitive function.

Authors:  E D Levin
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

9.  Characteristics of tail-tremor induced by nicotine in rats.

Authors:  K Suemaru; R Oishi; Y Gomita
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-08       Impact factor: 3.000

10.  Smoking stimuli from the terminal phase of cigarette consumption may not be cues for smoking in healthy smokers.

Authors:  Ronald F Mucha; Paul Pauli; Markus Weber; Markus Winkler
Journal:  Psychopharmacology (Berl)       Date:  2008-08-15       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.